Leukaemia (chronic lymphocytic, relapsed) - rituximab: appeal
Leukaemia (chronic lymphocytic, relapsed) - rituximab: background information on the technology appraisal
Leukaemia (chronic lymphocytic, relapsed) - rituximab: notice of appeal
Leukaemia (chronic lymphocytic, relapsed) - rituximab: appeal announcement
Leukaemia (chronic lymphocytic, relapsed) - rituximab: appeal decision
This page was last updated: 16 August 2010